MedXY

Not signed in Sign in / Register

Skip to content

Specialties
Clinical Updates
Medical News
iDoctor

Specialties
Clinical Updates
Medical News
iDoctor

Search for:

facebook.com
twitter.com
t.me
instagram.com
youtube.com

Home
news
Prenatal Maternal Phosphatidylcholine and Children’s Behavior and Cognition through 4 Years of Age: Randomized Clinical Trial

Posted innews OB/GYN & Women's Health Pediatrics

Prenatal Maternal Phosphatidylcholine and Children’s Behavior and Cognition through 4 Years of Age: Randomized Clinical Trial

Posted by

By MedXY 10/25/2026No Comments

Background

Objectives

Study Design and Methods

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

Sign in / Register

Tags:

child cognition fetal brain development phosphatidylcholine prenatal supplements social behavior

Last updated on 10/20/2026

Post navigation

Previous Post

Vascular Risk Factors as Key Contributors to Late-Onset Epilepsy: Insights from a Large US Cohort Meta-Analysis

Next Post

Mesh Position Matters: Patient-Reported Outcomes After Elective Incisional Hernia Repair in a Danish Nationwide Cohort

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply Cancel reply

You must be logged in to post a comment.

Enhancing Post-Stroke Physical Activity Through Telehealth and Wearable Technology: A Feasibility Randomised Controlled Trial
Advancing Dental Education: Repair Versus Replacement of Defective Composite Restorations in Canadian Dental Schools
Immunogenicity and Safety of Fractional 17DD Yellow Fever Vaccine Doses in Young Children: Evidence from a Phase 4 Randomised Trial in Uganda and Broader Context
Enhancing Prehospital Pediatric Ventilation Quality with Real-Time Feedback Devices: Insights from a Randomized Study
Nerandomilast Shows Promise in Slowing Progressive Pulmonary Fibrosis in Autoimmune Disease: Insights from the FIBRONEER-ILD Trial

About us
Contact us
MedXY story
Privacy Policy
Subscribe Now!
账号

English
日本語
Tiếng Việt
中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.